Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 4
1(16.7%)
6Total
N/A(5)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT05249205Not ApplicableTerminated

The Effect of Training Frequency on Improvements in VO2max With REHIT

Role: collaborator

NCT05260905Completed

Predictors of Affective Responses to Sprint Interval Exercise

Role: collaborator

NCT04216836Not ApplicableCompleted

One Week of Magnesium Supplementation Lowers IL-6, Perceived Pain and Increases Post Exercise Blood Glucose in Response to Downhill Running

Role: lead

NCT03463642Not ApplicableCompleted

The Efficacy of Different Vitamin D Supplementation Delivery Methods

Role: collaborator

NCT01569191Phase 4Completed

Non-Pharmaceutical Treatment of Seasonal Allergic Conjunctivitis

Role: collaborator

NCT03205241Not ApplicableCompleted

Effect of 4 Weeks Fish Oil Supplementation on Cycling Performance in Healthy Male Cyclists

Role: collaborator

NCT02266316Not ApplicableUnknown

Use of an Air Warming Mask for Exercise in Patients With COPD V1.0

Role: lead

All 7 trials loaded